These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 4006379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl.
    Hurwitz A, Karim A, Burns TS.
    J Clin Pharmacol; 1987 Nov; 27(11):855-61. PubMed ID: 3429692
    [Abstract] [Full Text] [Related]

  • 3. Food-induced changes in theophylline absorption from controlled-release formulations. Part II. Importance of meal composition and dosing time relative to meal intake in assessing changes in absorption.
    Karim A, Burns T, Janky D, Hurwitz A.
    Clin Pharmacol Ther; 1985 Dec; 38(6):642-7. PubMed ID: 4064466
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
    Weinberger MM.
    Pharmacotherapy; 1984 Dec; 4(4):181-98. PubMed ID: 6483637
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma.
    Vaughan LM, Milavetz G, Weinberger MM, Smith GD, Harris JB.
    Ther Drug Monit; 1988 Dec; 10(4):395-400. PubMed ID: 3059587
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of time of dose in relation to food on the bioavailability of Theo-Dur Sprinkle at steady state in asthmatic children.
    Birkett DJ, Lines DR, Kneebone GM, Green B, Hughes HM.
    Clin Pharmacol Ther; 1989 Mar; 45(3):305-11. PubMed ID: 2920505
    [Abstract] [Full Text] [Related]

  • 12. Bioavailability of four slow-release theophylline formulations in the beagle dog.
    Koritz GD, McKiernan BC, Neff-Davis CA, Munsiff IJ.
    J Vet Pharmacol Ther; 1986 Sep; 9(3):293-302. PubMed ID: 3761420
    [Abstract] [Full Text] [Related]

  • 13. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I.
    Ohmori N, Inotsume N, Matsukura M, Higashi A, Iwaoku R, Tobino Y, Nakano M, Matsuda I.
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN, Calcutt L, Hodder RV, Stewart JH, Aitken TL.
    Am J Med; 1988 Jul 29; 85(1B):48-53. PubMed ID: 3041826
    [Abstract] [Full Text] [Related]

  • 17. Influence of hyperlipidic food on the kinetics of slow-release formulations of theophylline.
    Brazier JL, Benchekroun Y, Gillet A, Andre C.
    Eur J Clin Pharmacol; 1989 Jul 29; 37(1):85-90. PubMed ID: 2591470
    [Abstract] [Full Text] [Related]

  • 18. Absorption of sustained-release theophylline tablets.
    Fagerström PO, Heintz L.
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul 29; 21(7):359-62. PubMed ID: 6885207
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.